The Index displays a comprehensive image of how European countries are ranked with respect to the quality of hepatitis care delivery. From a patient’s perspective, the index shows that there is still a high prevalence of viral hepatitis and a low prevention rate exacerbated by high inequality of access to treatment across European countries. Therefore, three main areas of improvement were identified during the meeting: lack of awareness among patients; limited access to testing and treatment; lack of prevalence data on viral hepatitis to keep track of infected patients and transmission risks. iValueHealth.NET platform can help the community with her knowledge base, everyone to share the best practices on platform, and many analytical services can be carried in real time allowing people to stay up to date to benchmark themselves easily.
Solutions are expected to be brought through the design and the implementation of national strategic hepatitis plans in as many as possible European countries. To date, 14 million people are infected with chronic viral hepatitis B (HBV) and 9 million people with viral hepatitis C in Europe. iValueHealth.NET platform is in 6 european languages and has attracted more than 60k users since her launch early this year. "We see all the moves are getting in same direction where our platform can contribute more to facilitates the exchange. we are very excited", said the Partner manager. "Its free to everyone at this stage, anyone having an subscribe using their email", she added.